These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29201920)

  • 1. Diabetic Nephropathy: From Pathophysiology to Treatment.
    Shen Z; Fang Y; Xing T; Wang F
    J Diabetes Res; 2017; 2017():2379432. PubMed ID: 29201920
    [No Abstract]   [Full Text] [Related]  

  • 2. Adequate vascular repair is relevant to improving renal perfusion and function following vasodilators in normoalbuminuric type 2 diabetic nephropathy.
    Futrakul N; Futrakul P
    Am J Kidney Dis; 2009 Sep; 54(3):583-4. PubMed ID: 19700066
    [No Abstract]   [Full Text] [Related]  

  • 3. Efficacy of statins in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials.
    Shen X; Zhang Z; Zhang X; Zhao J; Zhou X; Xu Q; Shang H; Dong J; Liao L
    Lipids Health Dis; 2016 Oct; 15(1):179. PubMed ID: 27733168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of combined lipoic acid and pyridoxine on albuminuria, advanced glycation end-products, and blood pressure in diabetic nephropathy.
    Noori N; Tabibi H; Hosseinpanah F; Hedayati M; Nafar M
    Int J Vitam Nutr Res; 2013; 83(2):77-85. PubMed ID: 24491880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ethyl pyruvate ameliorates albuminuria and glomerular injury in the animal model of diabetic nephropathy.
    Ju KD; Shin EK; Cho EJ; Yoon HB; Kim HS; Kim H; Yang J; Hwang YH; Ahn C; Oh KH
    Am J Physiol Renal Physiol; 2012 Mar; 302(5):F606-13. PubMed ID: 22129969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of short-term inhibition of prostaglandin synthesis on glomerular filtration rate and microalbuminuria in patients with incipient diabetic nephropathy.
    van den Berg BW; Kruseman AC; van Geel JL; Cornelissen P; Mulder AW
    Neth J Med; 1988 Oct; 33(3-4):106-12. PubMed ID: 3226444
    [No Abstract]   [Full Text] [Related]  

  • 7. Diabetic nephropathy. Aspects of pathophysiology and treatment.
    Hansen HP
    Dan Med Bull; 2003 Nov; 50(4):401-22. PubMed ID: 14694854
    [No Abstract]   [Full Text] [Related]  

  • 8. Management of Hypertension in Diabetic Nephropathy: How Low Should We Go?
    Sternlicht H; Bakris GL
    Blood Purif; 2016; 41(1-3):139-43. PubMed ID: 26766168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Over 11 years of stable renal function after remission of nephrotic-range proteinuria in type I diabetics treated with an ACE inhibitor.
    McGregor D; Bailey RR
    Nephron; 1997; 76(3):270-5. PubMed ID: 9226226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy of different antihypertensive drugs in human diabetic nephropathy: an updated meta-analysis.
    Weidmann P; Schneider M; Böhlen L
    Nephrol Dial Transplant; 1995 Oct; 10 Suppl 9():39-45. PubMed ID: 8643207
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diabetic nephropathy in children and adolescents].
    Dumas R
    Arch Pediatr; 1994 May; 1(5):455-7. PubMed ID: 7951828
    [No Abstract]   [Full Text] [Related]  

  • 12. Glomerular filtration rate and albuminuria: twin manifestations of nephropathy in diabetes.
    de Boer IH; Steffes MW
    J Am Soc Nephrol; 2007 Apr; 18(4):1036-7. PubMed ID: 17360946
    [No Abstract]   [Full Text] [Related]  

  • 13. Finerenone for Albuminuria in Patients With Diabetic Nephropathy.
    Feng Y; Zeng X; Fu P
    JAMA; 2016 Jan; 315(3):305-6. PubMed ID: 26784783
    [No Abstract]   [Full Text] [Related]  

  • 14. Finerenone for Albuminuria in Patients With Diabetic Nephropathy--Reply.
    Bakris GL; Nowack C
    JAMA; 2016 Jan; 315(3):306. PubMed ID: 26784785
    [No Abstract]   [Full Text] [Related]  

  • 15. Tocotrienol-Rich Vitamin E from Palm Oil (Tocovid) and Its Effects in Diabetes and Diabetic Nephropathy: A Pilot Phase II Clinical Trial.
    Tan SMQ; Chiew Y; Ahmad B; Kadir KA
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30227659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic nephropathy: Nonsteroidal MRA added to RAS blockade reduces albuminuria.
    Weir MR
    Nat Rev Nephrol; 2015 Dec; 11(12):691-2. PubMed ID: 26460357
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood pressure, hypertension, RAAS blockade, and drug therapy in diabetic kidney disease.
    Yamout H; Lazich I; Bakris GL
    Adv Chronic Kidney Dis; 2014 May; 21(3):281-6. PubMed ID: 24780456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.
    de Zeeuw D; Remuzzi G; Parving HH; Keane WF; Zhang Z; Shahinfar S; Snapinn S; Cooper ME; Mitch WE; Brenner BM
    Kidney Int; 2004 Jun; 65(6):2309-20. PubMed ID: 15149345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Microalbuminuria in incipient diabetic nephropathy].
    Mosora N
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1986; 38(6):549-54. PubMed ID: 2882586
    [No Abstract]   [Full Text] [Related]  

  • 20. Endothelial dysfunction and inflammation predict development of diabetic nephropathy in the Irbesartan in Patients with Type 2 Diabetes and Microalbuminuria (IRMA 2) study.
    Persson F; Rossing P; Hovind P; Stehouwer CD; Schalkwijk CG; Tarnow L; Parving HH
    Scand J Clin Lab Invest; 2008; 68(8):731-8. PubMed ID: 18609080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.